Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Operating Expenses | 3,684 | 1,320 | 1,845 | 1,674 | 2,698 |
| Operating Income | -3,684 | -1,320 | -1,845 | -1,674 | -2,698 |
| Interest Expense | 88 | N/A | N/A | N/A | N/A |
| Other Income | -1,610 | -24 | 54 | 58 | -40 |
| Pre-tax Income | -5,382 | -1,344 | -1,791 | -1,616 | -2,738 |
| Net Income Continuous | -5,382 | -1,344 | -1,791 | -1,616 | -2,738 |
| Net Income | $-5,382 | $-1,344 | $-1,791 | $-1,616 | $-2,738 |
| EPS Basic Total Ops | -0.05 | -0.02 | -0.03 | -0.03 | -0.11 |
| EPS Basic Continuous Ops | -0.05 | -0.02 | -0.03 | -0.03 | -0.11 |
| EPS Diluted Total Ops | -0.05 | -0.02 | -0.03 | -0.03 | -0.11 |
| EPS Diluted Continuous Ops | -0.05 | -0.02 | -0.03 | -0.03 | -0.11 |
| EBITDA(a) | $-5,266 | $-1,317 | $-1,841 | $-1,670 | $-2,691 |